Physician

Mashood Ahmad, MD

According to 2025 Medicare claims, Mashood Ahmad, MD (NPI: 1043232846) practices nephrology in the Rockford, IL market, with the plurality of this provider's patient population coming from Winnebago, IL. This provider's primary affiliated billing organization is RNA OF ROCKFORD, PLLC (NPI: 1336326388; TIN: 26-1497110) and primary practice location at 61107-5089.

Ahmad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 819 traditional Medicare patients, billed 4,947 HCPCS/CPT codes, and received $293,095 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,821 prescription claims across 429 beneficiaries totaling $390,283 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 24 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	779	7,068	$225,840
2016	820	7,995	$394,328
2017	868	9,159	$289,924
2018	838	10,441	$292,899
2019	780	3,704	$268,627
2020	782	3,798	$270,920
2021	900	4,248	$318,785
2022	744	3,131	$257,799
2023	806	4,022	$269,759
2024	819	4,947	$293,095

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	153	747	$177,855
2016	203	951	$198,804
2017	214	1,019	$161,657
2018	197	856	$62,429
2019	194	743	$79,657
2020	179	794	$83,614
2021	237	906	$64,913
2022	289	1,078	$80,806
2023	359	1,502	$176,506
2024	429	1,821	$390,283

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	26	$261
2020	N/R	24	$249
2021	N/R	27	$190
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	24	$1,275

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	455	692	$86
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	165	566	$60
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	124	734	$50
99439	Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month	120	407	$38
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	446	546	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	399	15,849	$296,138
Jardiance	Empagliflozin	55	2,700	$49,261
Calcitriol	Calcitriol	385	28,062	$7,523
Dapagliflozin	Dapagliflozin Propanediol	13	390	$6,383
Sevelamer Carbonate	Sevelamer Carbonate	23	1,294	$3,829

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	12	$1,049
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	12	$226

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Mashood Ahmad, MD?

Tedicare shows public-source Medicare data for Mashood Ahmad, MD (NPI 1043232846), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mashood Ahmad, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mashood Ahmad, MD?

Mashood Ahmad, MD is linked to RNA OF ROCKFORD, PLLC (billing NPI 1336326388) in the available physician profile data.

Does Mashood Ahmad, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.